Alexandra Gatzemeyer joins Executive Board of Sartorius to lead the Lab Products & Services division
The Supervisory Board of Germany’s Sartorius AG has appointed Alexandra Gatzemeyer, Ph.D., as Member of the Executive Board, effective May 1, 2023.
Alexandra Gatzemeyer will succeed Gerry Mackay, Board Member and Head of the Lab Products & Services division, who will hand over duties in the course of May and June to ensure a smooth transition at the helm of this division. After stepping down as Executive Board member as of June 16, Gerry Mackay will continue to support Sartorius in various cross-divisional tasks and initiatives.
Alexandra Gatzemeyer currently leads the LPS Sales & Services organization at Sartorius. During her more than 18 years tenure with the company, she served in various senior leadership roles including Product Management, Human Resources Management, and as Managing Director of a country organization. Alexandra holds a Ph.D. in pharmaceutical chemistry and pharmacology from the St. Petersburg State Chemical and Pharmaceutical University.
From June 16, the Sartorius Executive Board will thus consist of the four following members: Dr. Joachim Kreuzburg, Chairman and CEO; Dr. René Fáber, Head of Bioprocess Solutions; Alexandra Gatzemeyer, Head of Lab Products & Services; and Rainer Lehmann, Chief Financial Officer.